FDA 483 - Hellermann Dairy - February 18, 2022

Hellermann Dairy in Melrose, MN, was cited for significant issues related to drug residues in food-producing animals. The inspection revealed that an animal was offered for interstate commerce with florfenicol residues above established tolerances due to failure to observe the required withdrawal period. Additionally, the firm failed to review treatment records to ensure proper drug withdrawal and administered animal drugs contrary to label directions without a valid veterinary/client/patient relationship.